This Stock Is Likely To Outperform Abbott Laboratories
- Wednesday, September 29, 2021, 7:41
- Market
- Add a comment
We think that Dexcom stock currently is a better pick compared to Abbott stock, despite Dexcom being more expensive of the two. Dexcom trades at about 25x trailing revenues, compared to just 5x for Abbott. Although both the companies have benefited from the rise in demand for wearable continuous…
About the Author
admin123 has written 23404 stories on this site.
